These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8157556)

  • 1. Determination of 6-beta-bromopenicillanic acid (brobactam) in human serum by high-performance liquid chromatography (HPLC) using solid phase extraction for sample preparation.
    Woodcock JM; Wolstenholme MR; Andrews JM; Wise R
    J Antimicrob Chemother; 1994 Jan; 33(1):157-61. PubMed ID: 8157556
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of 6 beta-bromopenicillanic acid (brobactam) in human serum and urine by high-performance liquid chromatography.
    Kissmeyer-Nielsen AM
    J Chromatogr; 1988 Apr; 426(2):425-30. PubMed ID: 2839533
    [No Abstract]   [Full Text] [Related]  

  • 3. High-performance liquid chromatographic determination of tazobactam by precolumn derivatization.
    Peyrin E; Guillaume Y; Guinchard C
    J Chromatogr B Biomed Appl; 1995 Oct; 672(1):160-4. PubMed ID: 8590930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enzyme determination in vitro of inhibitor activity of beta-lactamase from tazobactam. Comparison with high performance liquid chromatography].
    Sotto A; Brunschwig C; Ramuz M; Jourdan J
    Pathol Biol (Paris); 1997 Jan; 45(1):77-81. PubMed ID: 9097851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of inactivation of beta-lactamase I by 6 beta-bromopenicillanic acid.
    Knott-Hunziker V; Orlek BS; Sammes PG; Waley SG
    Biochem J; 1980 Jun; 187(3):797-802. PubMed ID: 6331385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid determination of sulbactam and tazobactam in human serum by high-performance liquid chromatography.
    Guillaume Y; Peyrin E; Guinchard C
    J Chromatogr B Biomed Appl; 1995 Mar; 665(2):363-71. PubMed ID: 7795816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of Bacillus cereus beta-lactamase I by 6 beta-bromopenicillanic acid: kinetics.
    Loosemore MJ; Cohen SA; Pratt RF
    Biochemistry; 1980 Aug; 19(17):3990-5. PubMed ID: 6250581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The concept of beta-lactamase inhibitor].
    Jarlier V
    Presse Med; 1998 Sep; 27 Suppl 4():17-8. PubMed ID: 9798480
    [No Abstract]   [Full Text] [Related]  

  • 9. Liquid chromatographic assay of beta-lactamase inhibitors in human serum and urine using a hollow-fiber postcolumn reactor.
    Haginaka J; Wakai J; Yasuda H
    Anal Chem; 1987 Jan; 59(2):324-7. PubMed ID: 3039871
    [No Abstract]   [Full Text] [Related]  

  • 10. 6 beta-Bromopenicillanic acid inactivates beta-lactamase I.
    Knott-Hunziker V; Orlek BS; Sammes PG; Waley SG
    Biochem J; 1979 Jan; 177(1):365-7. PubMed ID: 218563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and tissue penetration of ampicillin and brobactam following oral administration of 2085P.
    Wise R; O'Sullivan N; Johnson J; Andrews JM
    Antimicrob Agents Chemother; 1992 May; 36(5):1002-4. PubMed ID: 1324634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-beta-bromopenicillanic acid, a potent beta-lactamase inhibitor.
    Pratt RF; Loosemore MJ
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4145-9. PubMed ID: 212736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved high-performance liquid chromatographic method with a solid-phase extraction for the determination of piperacillin and tazobactam: application to pharmacokinetic study of different dosage in Chinese healthy volunteers.
    Xia CH; Xiong YQ; Wang GJ
    Biomed Chromatogr; 2007 Jul; 21(7):680-6. PubMed ID: 17385803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro evaluation of ampicillin/brobactam and comparison with other beta-lactam antibiotics.
    Melchior NH; Keiding J
    J Antimicrob Chemother; 1991 Jan; 27(1):29-40. PubMed ID: 1646779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the chemistry of beta-lactamase inhibition by 6 beta-bromopenicillanic acid.
    Orlek BS; Sammes PG; Knott-Hunziker V; Waley SG
    J Chem Soc Perkin 1; 1980; 10():2322-9. PubMed ID: 6253512
    [No Abstract]   [Full Text] [Related]  

  • 16. Ceftolozane/tazobactam for the treatment of complicated urinary tract and intra-abdominal infections.
    Bassetti M; Righi E
    Future Microbiol; 2015; 10(2):151-60. PubMed ID: 25689527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species.
    Gavin PJ; Suseno MT; Thomson RB; Gaydos JM; Pierson CL; Halstead DC; Aslanzadeh J; Brecher S; Rotstein C; Brossette SE; Peterson LR
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2244-7. PubMed ID: 16723596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the thiol RTEM-1 beta-lactamase by 6-beta-bromopenicillanic acid. Identity of the primary active-site nucleophile.
    Knap AK; Pratt RF
    Biochem J; 1987 Oct; 247(1):29-33. PubMed ID: 2825657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-performance liquid chromatographic determination of 6-aminopenicillanic acid by postcolumn alkaline degradation.
    Haginaka J; Wakai J
    Anal Biochem; 1986 Oct; 158(1):146-50. PubMed ID: 3026201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an
    VanScoy BD; Tenero D; Turner S; Livermore DM; McCauley J; Conde H; Bhavnani SM; Rubino CM; Ambrose PG
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.